BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38130397)

  • 1.
    Szalat A; Shpitzen S; Pollack R; Mazeh H; Durst R; Meiner V
    Front Endocrinol (Lausanne); 2023; 14():1254156. PubMed ID: 38130397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnicity of Patients With Germline
    Guan B; Welch JM; Vemulapalli M; Li Y; Ling H; Kebebew E; Simonds WF; Marx SJ; Agarwal SK
    J Endocr Soc; 2017 May; 1(5):488-499. PubMed ID: 29264504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.
    Guan B; Welch JM; Sapp JC; Ling H; Li Y; Johnston JJ; Kebebew E; Biesecker LG; Simonds WF; Marx SJ; Agarwal SK
    Am J Hum Genet; 2016 Nov; 99(5):1034-1044. PubMed ID: 27745835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant Tyr 394Ser in the
    Tolkin L; Klein V; Frankel M; Altarescu G; Beeri R; Munter G
    J Endocr Soc; 2023 Jun; 7(7):bvad086. PubMed ID: 37362385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
    Vincze S; Peters NV; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Riccardi A; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2021-e2026. PubMed ID: 34967908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole exome sequencing in familial isolated primary hyperparathyroidism.
    Cetani F; Pardi E; Aretini P; Saponaro F; Borsari S; Mazoni L; Apicella M; Civita P; La Ferla M; Caligo MA; Lessi F; Mazzanti CM; Torregossa L; Oppo A; Marcocci C
    J Endocrinol Invest; 2020 Feb; 43(2):231-245. PubMed ID: 31486992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
    Marx SJ
    J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
    Marx SJ; Lourenço DM
    Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.
    Canaff L; Guarnieri V; Kim Y; Wong BYL; Nolin-Lapalme A; Cole DEC; Minisola S; Eller-Vainicher C; Cetani F; Repaci A; Turchetti D; Corbetta S; Scillitani A; Goltzman D
    Eur J Endocrinol; 2022 Feb; 186(3):351-366. PubMed ID: 35038313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
    Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
    Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
    J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
    Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
    J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort.
    Mariathasan S; Andrews KA; Thompson E; Challis BG; Wilcox S; Pierce H; Hale J; Spiden S; Fuller G; Simpson HL; Fish B; Jani P; Seetho I; Armstrong R; Izatt L; Joshi M; Velusamy A; Park SM; Casey RT
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):409-418. PubMed ID: 32430905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Concepts About Familial Isolated Hyperparathyroidism.
    Marx SJ
    J Clin Endocrinol Metab; 2019 Sep; 104(9):4058-4066. PubMed ID: 30848815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?
    Coppin L; Dufosse M; Romanet P; Giraud S; North MO; Cardot Bauters C; Borson-Chazot F; Duchesne L; Métallo M; Lovecchio T; Barlier A; Odou MF
    Eur J Endocrinol; 2020 Jan; 182(1):57-65. PubMed ID: 31671402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
    Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.
    El Lakis M; Nockel P; Guan B; Agarwal S; Welch J; Simonds WF; Marx S; Li Y; Nilubol N; Patel D; Yang L; Merkel R; Kebebew E
    Surgery; 2018 Jan; 163(1):31-34. PubMed ID: 29108698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Missense
    Bletsis P; Metzger R; Nelson JA; Gasparini J; Alsayed M; Milas M
    AACE Clin Case Rep; 2022; 8(5):194-198. PubMed ID: 36189134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.